https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1530583/full
Frontiers | Effect of bispecific recombinant oncolytic adenovirus carrying apoptin on apoptosis of...
ObjectiveIn this study, breast cancer cell line MCF-7 was infected with recombinant oncolytic adenovirus Ad-VT expressing apopsin protein, and its anti-tumou...
oncolytic adenovirusfrontierseffectrecombinant
https://www.researchandmarkets.com/reports/6076065/oncolytic-adenovirus-market-report
Oncolytic Adenovirus Market Report 2026 - Research and Markets
The Oncolytic Adenovirus Market, valued at USD 143.57B in 2026, is projected to reach USD 195.85B by 2030, growing at a 8.1% CAGR.
oncolytic adenovirusmarket report2026 researchmarkets
https://pmc.ncbi.nlm.nih.gov/articles/PMC6025169/
Designer Oncolytic Adenovirus: Coming of Age - PMC
The licensing of talimogene laherparepvec (T-Vec) represented a landmark moment for oncolytic virotherapy, since it provided unequivocal evidence for the...
coming of ageoncolytic adenovirusdesignerpmc
https://www.dkfz.de/virotherapie/oncolytic-adenovirus-group
Oncolytic Adenovirus Group - Deutsches Krebsforschungszentrum
oncolytic adenovirusgroupdeutsches
https://pmc.ncbi.nlm.nih.gov/articles/PMC9365362/
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent...
Testing safety of Delta24-RGD (DNX-2401), an oncolytic adenovirus, locally delivered by convection enhanced delivery (CED) in tumor and surrounding brain of...
convection enhanced delivery